REMINDER: Our user survey closes TODAY, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Cyanconnode, Rosslyn Data rise on contract wins

Mon, 22nd Aug 2022 11:03

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Cyanconnode Holdings PLC, up 29% at 19.00 pence, 12-month range 11.00p-29.85p. The narrowband radio frequency smart mesh networks firm says Indian subsidiary has received its largest-ever order. CyanConnode India Pvt Ltd has received an order from Genus Power Infrastructures Ltd for one million Omnimesh modules, together with advanced metering infrastructure, standards-based hardware, Omnimesh head-end software, perpetual license and a support and maintenance contract. The support and maintenance contract runs for eight years, starting upon completion of the installation phase.

----------

Rosslyn Data Technologies PLC, up 12% at 2.36p, 12-month range 1.50p-5.98p. The data management and analytics service provider wins first enterprise customer through partnership with indirect procurement service provider Chain IQ Group AG. Says initial contract is "of relatively small monetary value" but expects further contracts to come from partnership. Chief Executive Paul Watts says deal highlights value of partnership with Chain IQ.

----------

Open Orphan PLC, up 5.9% at 11.91p, 12-month range 10.00p-27.75p. The pharmaceutical services firm says subsidiary hVIVO Ltd has won a GBP10.4 million contract. Open Orphan says the contract has been signed with an "existing top five global pharmaceutical client". This is the third human challenge contract signed with the client, it adds.

----------

AIM - LOSERS

----------

Artemis Resources Ltd, down 11% at 2.05p, 12-month range 1.44p-5.00p. The miner says no significant nickel or copper results are found in laboratory analyses of samples from the first drill hole at the Osborne nickel prospect. Further, in a separate statement regarding its Greater Carlow project, holes ARC395 and ARC396 "did not return any significant mineralisation, in line with the offset of the lodes already discovered by holes ARC403 and ARC404," the Perth-based miner with gold, copper and cobalt projects in Australia adds.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
9 Jul 2021 11:42

Open Orphan inks contract with AIM ImmunoTech to test Ampligen drug

Open Orphan inks contract with AIM ImmunoTech to test Ampligen drug

Read more
9 Jul 2021 10:52

AIM WINNERS & LOSERS: Evgen disappointed as SFX-01 flops study hurdle

AIM WINNERS & LOSERS: Evgen disappointed as SFX-01 flops study hurdle

Read more
9 Jul 2021 10:20

Open Orphan subsidiary scores 'significant contract' with AIM ImmunoTech

(Sharecast News) - Clinical research organisation Open Orphan's hVIVO subsidiary has signed "a significant contract" to test AIM ImmunoTech's antiviral candidate, Ampligen.

Read more
17 Jun 2021 14:34

Cathal Friel-led Poolbeg Pharma set to float on AIM

(Sharecast News) - Infectious disease specialist Poolbeg Pharma is to list on the London Stock Exchange's junior market, AIM, with a view to raising the funds needed to develop its product pipeline.

Read more
17 Jun 2021 14:05

Open Orphan reports widened 2020 loss; Poolbeg mulls London float

Open Orphan reports widened 2020 loss; Poolbeg mulls London float

Read more
17 Jun 2021 11:43

AIM WINNERS & LOSERS: Midatech Pharma up 90% on Q-Sphera breakthrough

AIM WINNERS & LOSERS: Midatech Pharma up 90% on Q-Sphera breakthrough

Read more
16 Jun 2021 16:00

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
19 May 2021 19:33

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

Read more
10 May 2021 13:37

TRADING UPDATES: Begbies buys finance broker; Amino Tech makes US bid

TRADING UPDATES: Begbies buys finance broker; Amino Tech makes US bid

Read more
10 May 2021 09:30

Open Orphan subsidiary signs contract to make Covid-19 challenge virus

(Sharecast News) - Specialist pharmaceutical services contract research organisation Open Orphan announced on Monday that its subsidiary hVIVO has signed a contract with Imperial College London, as part of a Wellcome Trust-funded initiative to manufacture a SARS-CoV-2 challenge virus.

Read more
6 May 2021 15:33

EXECUTIVE CHANGES: New Cenkos CEO gets FCA nod; Feedback hires CFO

EXECUTIVE CHANGES: New Cenkos CEO gets FCA nod; Feedback hires CFO

Read more
9 Apr 2021 10:33

Open Orphan launches new data platform to combat infectious diseases

Open Orphan launches new data platform to combat infectious diseases

Read more
26 Mar 2021 14:36

TRADING UPDATES: Renew to buy J Browne; Idox in good start to year

TRADING UPDATES: Renew to buy J Browne; Idox in good start to year

Read more
25 Mar 2021 17:14

TRADING UPDATES: SpaceandPeople swings to loss in 2020 amid virus

TRADING UPDATES: SpaceandPeople swings to loss in 2020 amid virus

Read more
25 Mar 2021 15:34

Open Orphan makes progress with Covid-19 characterisation study

(Sharecast News) - Specialist pharmaceutical services clinical research company Open Orphan updated the market on its world-first Covid-19 characterisation study on Thursday, reporting that the first three volunteers had now completed the quarantine phase.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.